Regencell Bioscience Holdings Ltd Ratios

Ratios Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Profitability
EBT Margin -3,890.42%-32,714.00%-2,868.49%-1,168.18%
EBIT Margin -3,990.42%-32,814.00%-2,968.49%-1,268.18%
EBITDA Margin -3,890.42%-32,714.00%-2,909.50%-1,157.23%
Operating Margin -3,990.42%-32,814.00%-2,968.49%-1,268.18%
Net Margin -3,890.42%-32,073.84%-2,819.03%-1,168.18%
FCF Margin -2,216.57%-26,051.82%-2,361.26%-1,072.83%
Valuation
Enterprise Value 437.48M299.82M43.72M8,426.09M
Market Capitalization 437.48M299.82M43.72M8,426.09M
Return Ratios
Return on Sales -38.90%-327.14%-28.68%-11.68%